Results Wire: US FDA Advisory Committee Votes to Recommend Further Study of Translarna by PTC Therapeutics for Nonsense Mutation Dystrophinopathy Report
Results Wire: US FDA Advisory Committee Votes to Recommend Further Study of Translarna by PTC Therapeutics for Nonsense Mutation Dystrophinopathy Report